康惠制药(603139) - 2020 Q3 - 季度财报

Financial Performance - Operating income decreased by 4.12% to CNY 292,452,140.76 for the first nine months of the year[6] - Net profit attributable to shareholders decreased by 8.58% to CNY 29,553,980.76 for the first nine months[6] - Basic earnings per share decreased by 6.25% to CNY 0.30[6] - The weighted average return on equity decreased by 0.31 percentage points to 2.98%[6] - Total operating revenue for the first three quarters of 2020 was ¥292,452,140.76, down 4.27% from ¥305,003,823.87 in the same period of 2019[28] - The company’s total profit for the first three quarters of 2020 was CNY 30,521,201.62, down from CNY 34,390,503.14 in the same period of 2019, indicating a decline of 11.0%[36] - Total profit for Q3 2020 was ¥15,782,518.61, down from ¥17,538,812.24 in Q3 2019, a decline of 10.03%[30] Assets and Liabilities - Total assets increased by 5.83% to CNY 1,196,573,113.18 compared to the end of the previous year[6] - Total liabilities increased to CNY 125,467,883.28, up from CNY 113,853,555.83 year-over-year, representing a growth of approximately 10.8%[19] - Current assets decreased to CNY 517,634,215.75 from CNY 729,329,924.40, a decline of about 29.0%[22] - Non-current assets increased to CNY 525,222,625.44 from CNY 313,969,789.88, reflecting a growth of approximately 67.3%[24] - Total equity rose to CNY 1,071,105,229.90, compared to CNY 1,016,824,896.06, marking an increase of about 5.3%[19] - The total debt-to-equity ratio stands at approximately 0.117, indicating a relatively low leverage position[19] Cash Flow - Cash flow from operating activities improved significantly, with a net amount of CNY 3,397,073.76 compared to a negative CNY 26,989,203.31 in the same period last year, representing a 112.59% increase[6] - Operating cash flow for the first three quarters of 2020 was negative at -11,920,903.68 RMB, compared to -24,506,780.15 RMB in the same period of 2019, showing an improvement[46] - Cash flow from investing activities showed a net outflow of CNY 108,723,474.41 in the first three quarters of 2020, contrasting with a net inflow of CNY 4,246,735.17 in the same period of 2019[42] Shareholder Information - The total number of shareholders reached 9,134 by the end of the reporting period[7] - The largest shareholder, Shaanxi Kanghui Holdings Co., Ltd., holds 39.65% of the shares, with 19,000,000 shares pledged[7] Government Support - Government subsidies recognized in the first nine months amounted to CNY 940,332.86[7] - Other income increased by 485.88% to ¥940,332.86 from ¥160,499.97, mainly due to an increase in government subsidies[12] Investment and Projects - Long-term equity investments rose by 178.65% to ¥81,079,696.89 from ¥29,097,336.66, attributed to increased investment projects[10] - Construction in progress surged by 215.32% to ¥241,683,450.37 from ¥76,647,763.11, mainly due to increased payments for investment projects[10] - The company has ongoing construction projects valued at CNY 210,450,875.01, up from CNY 68,026,473.71, indicating a focus on expansion[24] Other Financial Metrics - The company reported a significant increase in credit impairment losses, which rose by 933.21% to -¥3,674,216.51 from -¥355,610.07, indicating a higher provision for bad debts[12] - Financial expenses decreased by 76.45% to -¥2,181,539.93 from -¥1,236,364.17, primarily due to increased interest income from bank deposits[12] - Cash and cash equivalents decreased significantly to CNY 168,579,023.53 from CNY 280,814,817.30, a drop of about 40.0%[22]